Biopsy, Endomyocardial
Endomyocardial biopsy is a procedure used to procure a small portion of the endocardium and myocardium for histopathologic, ultrastructural or molecular studies. Endomyocardial biopsy requires skilled staff, equipped and multidisciplinary facility to handle the procedure as well as the obtained samples. The procedure requires admitting the patient to the hospital and careful monitoring throughout and up to 12-24 hours after the procedure.
The biopsy is performed with the patient under local anesthesia using echocardiographic or fluoroscopic guidance. The patient is monitored with electrocardiogram (ECG) and other vital signs throughout the procedure. For diseases such as post-allograft monitoring for rejection, a right-sided biopsy is generally preferred as it allows access via the internal jugular or femoral vein and minimizes complications. Occasionally, left-sided biopsy is indicated requiring access through an artery (radial or femoral). A bioptome is used to obtain samples from the interventricular septum. Imaging studies are carried out at the end of the procedure to detect any procedure-associated anatomic complications.
The procedure is generally safe and well-tolerated by most patients when performed by a skilled interventionalist. Potential complications include access site hematoma, arteriovenous fistula, vasovagal reaction, pneumothorax, hemothorax, transient right bundle branch block, transient arrhythmias, tricuspid regurgitation, pulmonary/systemic embolism and procedural anxiety. Rare but potentially life-threatening complications include right ventricular perforation, pericardial effusion leading to cardiac tamponade, malignant arrhythmias and tension pneumothorax.
- Management of cardiac allograft effectiveness/rejection status
- Diagnosis of cardiac tumors
- Management of non-ischemic heart failure and ventricular arrhythmia
- Diagnosis of suspected myocarditis and infiltrative cardiomyopathy
There are no universal reference ranges for endomyocardial biopsies. In general, a normal myocardial biopsy consists of benign cardiac muscle tissue with sparse to no inflammatory cells.
The biopsy fragments are generally fixed in formalin for histopathologic examination. If molecular studies are required, a portion of the sample should be cryopreserved or preserved in RNAse free medium. To allow for ultrastructural examination, if necessary, a portion should be fixed in glutaraldehyde.
- Virchows Arch. 2013 Jul;463(1):1-5. [PMID: 23748875]
- Cardiovasc Pathol. 2012 Jul-Aug;21(4):245-74. [PMID: 22137237]
- Cardiovasc Pathol. 2011 Sep-Oct;20(5):291-6. [PMID: 20934890]
- Mayo Clin Proc. 2011 Nov; 86(11): 1095–1102. [PMID: 22033254]
- Cardiovasc Clin. 1985;15(1):141-63. [PMID: 3916087]